Mylan N.V. Sees Signs of Improvement in the 4th Quarter
Weak North American sales continued to plague the drugmaker in the fourth quarter, but 2018 looks to be a much better year.
Thursday, March 1, 2018
Mylan N.V. Sees Signs of Improvement in the 4th Quarter
Mylan N.V. Sees Signs of Improvement in the 4th Quarter
Weak North American sales continued to plague the drugmaker in the fourth quarter, but 2018 looks to be a much better year.
Related Posts:
0 comments:
Post a Comment